Previous studies have shown that MYOF is strongly associated with tumour metastasis and aggressiveness in breast cancer [31], clear cell renal cell carcinoma [32], and pancreatic ductal adenocarcinoma [33]. This evidence concerns the gene MYOF and clear cell renal carcinoma.